Therapeutic Asset Ratings
2,003 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
(+)-VINCRISTINE
Chronic Myelomonocytic Leukemia
M.D. Anderson Cancer Center
P2
B
(60)
Vorinostat
B-Cell Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P2
B
(60)
Vorinostat
Non-Hodgkin Lymphoma
M.D. Anderson Cancer Center
P2
B
(60)
Sotorasib
Colorectal Cancer
M.D. Anderson Cancer Center
P3
B
(59)
Anti-Thymoglobulin, Rabbit
Myelodysplastic Syndrome With Excess Blasts
M.D. Anderson Cancer Center
P2
B
(59)
Benadryl
Acute Myeloid Leukemia
M.D. Anderson Cancer Center
P2
B
(59)
Cediranib
Cervical Squamous Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(59)
Cediranib
Lymphoproliferative Disorder
M.D. Anderson Cancer Center
P2
B
(59)
Cediranib
Metastatic Malignant Neoplasm in the Brain
M.D. Anderson Cancer Center
P2
B
(59)
Cediranib
Recurrent Malignant Neoplasm
M.D. Anderson Cancer Center
P2
B
(59)
Clofarabine
Adult Acute Lymphoblastic Leukemia
M.D. Anderson Cancer Center
P2
B
(59)
Clofarabine
Myelodysplastic/Myeloproliferative Neoplasm
M.D. Anderson Cancer Center
P2
B
(59)
Dexrazoxane
Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
M.D. Anderson Cancer Center
P2
B
(59)
Fludarabine
Adenocarcinoma
M.D. Anderson Cancer Center
P2
B
(59)
Fludarabine
Minimal Residual Disease
M.D. Anderson Cancer Center
P2
B
(59)
gsk1120212
Advanced Malignant Solid Neoplasm
M.D. Anderson Cancer Center
P2
B
(59)
HYDROMORPHON
AML
M.D. Anderson Cancer Center
P2
B
(59)
Ipilimumab
Bladder Transitional Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(59)
Ipilimumab
Renal Pelvis Urothelial Carcinoma
M.D. Anderson Cancer Center
P2
B
(59)
Ipilimumab
Ureter Transitional Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(59)
Ipilimumab
Urethra Transitional Cell Carcinoma
M.D. Anderson Cancer Center
P2
B
(59)
Ipilimumab
Urinary Bladder Cancer
M.D. Anderson Cancer Center
P2
B
(59)
Ipilimumab
Stage III Renal Pelvis Cancer AJCC v8
M.D. Anderson Cancer Center
P2
B
(59)
Ipilimumab
Ureter Cancer
M.D. Anderson Cancer Center
P2
B
(59)
Ipilimumab
Urethra Cancer
M.D. Anderson Cancer Center
P2
B
(59)
Showing 326 to 350 of 2,003 assets
Previous
Page 14 of 81
Next